24
Participants
Start Date
May 31, 2005
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Docetaxel
"One treatment cycle is defined as 21 days.~Docetaxel: 70 mg/m\^2 (60 mg/m\^2 was tested in Phase I as well), Intravenous, every 21 days."
Imatinib Mesylate
"One treatment cycle is defined as 21 days.~Imatinib Mesylate: 24-36 hours after Docetaxel, 600 mg (400 mg was tested in Phase I as well), orally, daily x 14 days."
Bellevue Hospital, New York
NYU Clinical Cancer Center, New York
NYU Tisch Hospital, New York
Collaborators (1)
Novartis
INDUSTRY
NYU Langone Health
OTHER